Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma

There are few data on the long‐term sequelae of axillary dissection among older breast carcinoma patients. We describe the impact of axillary dissection in a cohort of older women.

[1]  R. Kreienberg,et al.  Long-Term Morbidity Following Axillary Dissection in Breast Cancer Patients – Clinical Assessment, Significance for Life Quality and the Impact of Demographic, Oncologic and Therapeutic Factors , 2000, Breast Cancer Research and Treatment.

[2]  T. Field,et al.  Risk factors for a decline in upper body function following treatment for early stage breast cancer , 1999, Breast Cancer Research and Treatment.

[3]  U. C. Bureau.  Statistical Abstract of the United States , 2004 .

[4]  S. Edge,et al.  Patient and provider characteristics that affect the use of axillary dissection in older women with Stage I–II breast carcinoma , 2002, Cancer.

[5]  Y. Hwang,et al.  Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods. , 2001, Health services research.

[6]  R. Senie,et al.  Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis , 2001, Cancer.

[7]  D. Winchester,et al.  Lymphedema after sentinel lymphadenectomy for breast carcinoma , 2001, Cancer.

[8]  C. Begg,et al.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer. , 2001, Journal of the National Cancer Institute.

[9]  J. Coebergh,et al.  Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. , 2001, European journal of cancer.

[10]  E. Winer,et al.  NCCN Practice Guidelines for Breast Cancer. , 2000, Oncology.

[11]  S. Troyan,et al.  Patient preferences for axillary dissection in the management of early-stage breast cancer. , 2000, Journal of the National Cancer Institute.

[12]  Vincent Mor,et al.  The effect of less than definitive care on breast carcinoma recurrence and mortality , 2000, Cancer.

[13]  S. Edge,et al.  Patterns of breast carcinoma treatment in older women , 2000, Cancer.

[14]  A E Giuliano,et al.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  V. Klimberg.  The Path to Recurrence Is Paved With Good Intentions , 2000, Annals of Surgical Oncology.

[16]  J. Ragaz,et al.  A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma , 2000, Cancer.

[17]  Andreas Shamiyeh,et al.  Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma , 2000, Cancer.

[18]  S. Tage.  BREAST CANCER IN CALIFORNIA , 2000 .

[19]  A. Giuliano,et al.  Does Sentinel Lymphadenectomy Improve Staging and Alter Therapy in Elderly Women With Breast Cancer? , 2000, Annals of Surgical Oncology.

[20]  D. Berry,et al.  Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  P. Ganz,et al.  Quality of life of African‐American and white long term breast carcinoma survivors , 1999, Cancer.

[22]  L Cohen,et al.  Physical and psychological morbidity after axillary lymph node dissection for breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  E. Winer,et al.  Complications of axillary lymph node dissection for carcinoma of the breast , 1998, Cancer.

[24]  G. Lyman,et al.  Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  T. Lash,et al.  Re: prevalence of cancer. , 1998, Journal of the National Cancer Institute.

[26]  M. Levine,et al.  The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[27]  B Fisher,et al.  Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. , 1997, Journal of the National Cancer Institute.

[28]  K. Bland,et al.  Surgery of breast cancer , 1997, Current opinion in oncology.

[29]  L. Stitt,et al.  Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques. , 1997, Canadian journal of surgery. Journal canadien de chirurgie.

[30]  L. Tan,et al.  Segmental mastectomy and tamoxifen alone provide adequate locoregional control of breast cancer in elderly women. , 1997, The American surgeon.

[31]  A. Giuliano,et al.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. , 1997, Annals of surgery.

[32]  J. Gurwitz,et al.  Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Reiss,et al.  Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  B. Cady.  Is Axillary Lymph Node Dissection Necessary in Routine Management of Breast Cancer? No. , 1997, Important advances in oncology.

[35]  S. Martino,et al.  Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  H. Feigelson,et al.  T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection. , 1996, American journal of surgery.

[37]  J Stare,et al.  Explained variation in survival analysis. , 1996, Statistics in medicine.

[38]  R. Hiatt,et al.  Comorbidity and breast cancer survival: a comparison between black and white women. , 1996, Annals of epidemiology.

[39]  J. Samet,et al.  Determinants of survival in older cancer patients. , 1996, Journal of the National Cancer Institute.

[40]  W. Satariano,et al.  Limitations in upper-body strength associated with breast cancer: a comparison of black and white women. , 1996, Journal of clinical epidemiology.

[41]  C. Desch,et al.  The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. , 1996, Archives of internal medicine.

[42]  D W Kinne,et al.  Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes. , 1996, Important advances in oncology.

[43]  J. Graybill,et al.  Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome. , 1995, Radiology.

[44]  D. Coradini,et al.  Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus adjuvant tamoxifen. , 1995, British Journal of Cancer.

[45]  H. Andrews,et al.  Impact of Access and Social Context on Breast Cancer Stage at Diagnosis , 1995, Journal of health care for the poor and underserved.

[46]  P M Ravdin,et al.  Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. , 1994, Journal of the National Cancer Institute.

[47]  John E. Ware,et al.  SF-36 physical and mental health summary scales : a user's manual , 1994 .

[48]  J. Brisson,et al.  Arm problems and psychological distress after surgery for breast cancer. , 1993, Canadian journal of surgery. Journal canadien de chirurgie.

[49]  I Taylor,et al.  Assessment of morbidity from complete axillary dissection. , 1992, British Journal of Cancer.

[50]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[51]  J. Samet,et al.  Geographic variation in the treatment of localized breast cancer. , 1992, The New England journal of medicine.

[52]  Samuel Hellman,et al.  Important advances in oncology , 1991 .

[53]  R. Yancik,et al.  Cancer in the Elderly: Approaches to Early Detection and Treatment , 2004 .

[54]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[55]  D. Easton,et al.  Risk of lymphoedema following the treatment of breast cancer , 1986, The British journal of surgery.

[56]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[57]  W. Grove.  Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[58]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[59]  S. Kuwabara.  [Surgery of breast cancer]. , 1970, Geka chiryo. Surgical therapy.

[60]  L. Delatore.  THE PREVALENCE OF CANCER. , 1927, Science.

[61]  Margo J. Anderson,et al.  The Census , 1921, The Hospital.

[62]  H. Hunziker-Kramer.  Prevalence of Cancer , 1882, The Southern medical record.